8th Annual Tumour Models, San Francisco, CA, Jan 30-Feb 01, 2024

Conference

genOway presentation

Event
-
January 23, 2024

Jan 30-Feb 01, 2024

Implementing State-of-the-Art, Reproducible Preclinical Oncology Models to Accelerate Your Candidate’s Clinical Translatability

‍

8th Tumour Models San Francisco

‍

genOway’s presentation:

How to enhance translatability of immunotherapies in preclinical models

  • Outlining BRGSF-HIS mice: Immunodeficient mice displaying functional human lymphoid and myeloid compartments, without GvHD and side effects
  • Examining human cells functionality and assessing immune modulation induced by biologics in BRGSF-HIS model
  • Showcase of assessment of immune targeting agents in immune checkpoint humanized models

Other news & events

The 55th Annual Meeting of the Japanese Society for Immunology, Osaka, November 17-19, 2026
Conference
genOway presentation
Event
-
Nov 2026
Read on
Festival of Biologics, Basel Switzerland, October 13-15, 2026
Conference
genOway presentation
Event
-
Oct 2026
Read on
Lunch & Learn, October 7th, San Diego Biomedical Research Institute: Accelerating Drug Development Through Predictive and Translatable In Vivo Models
genOway presentation
Event
-
Oct 2026
Read on
BioJapan, Yokohama, October 7-9, 2026
Conference
genOway presentation
Event
-
Oct 2026
Read on
Lunch & Learn, October 6th, Salk Institute for Biological Studies: Accelerating Drug Development Through Predictive and Translatable In Vivo Models
genOway presentation
Event
-
Oct 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe